[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Cencora Stock Underperforming the Nasdaq?

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) sources and distributes pharmaceutical products. Valued at $53.5 billion by market cap, the company offers end-to-end pharmaceutical commercialization solutions, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and COR effortlessly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical distribution industry. COR’s strengths come from its strategic role in the healthcare value chain, diversified portfolio, and scale that gives it strong bargaining power. It uses cross-business synergies, brand...

Fundamentals

See More
  • Market Capitalization, $K 53,512,060
  • Shares Outstanding, K 194,561
  • Annual Sales, $ 321,333 M
  • Annual Income, $ 1,554 M
  • EBIT $ 4,536 M
  • EBITDA $ 5,604 M
  • 60-Month Beta 0.59
  • Price/Sales 0.16
  • Price/Cash Flow 12.51
  • Price/Book 14.67

Options Overview Details

View History
  • Implied Volatility 28.42% (+1.25%)
  • Historical Volatility 59.08%
  • IV Percentile 68%
  • IV Rank 54.06%
  • IV High 35.04% on 03/30/26
  • IV Low 20.63% on 06/25/25
  • Expected Move (DTE 10) 10.68 (3.90%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 466
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 15,406
  • Open Int (30-Day) 15,604
  • Expected Range 263.35 to 284.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $4.37
  • Number of Estimates 6
  • High Estimate $4.47
  • Low Estimate $4.31
  • Prior Year $4.00
  • Growth Rate Est. (year over year) +9.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
252.18 +8.61%
on 05/14/26
277.99 -1.47%
on 06/05/26
+13.23 (+4.91%)
since 05/08/26
3-Month
244.82 +11.88%
on 05/06/26
362.27 -24.39%
on 03/10/26
-84.15 (-23.59%)
since 03/06/26
52-Week
244.82 +11.88%
on 05/06/26
377.54 -27.45%
on 11/25/25
-14.64 (-5.21%)
since 06/06/25

Most Recent Stories

More News
Is Cencora Stock Underperforming the Nasdaq?

Cencora has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

$NASX : 26,062.79 (+1.37%)
MCK : 768.60 (-0.91%)
COR : 273.62 (-0.52%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

NEW YORK , June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR). Such investors are advised to contact...

COR : 273.62 (-0.52%)
Is McKesson Stock Underperforming the Dow?

McKesson has underperformed the Dow over the past year, but analysts are highly optimistic about the stock’s prospects.

MCK : 768.60 (-0.91%)
COR : 273.62 (-0.52%)
$DOWI : 50,921.52 (+0.11%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

NEW YORK , May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR). Such investors are advised to contact...

COR : 273.62 (-0.52%)
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer

Cencora reaffirms fiscal 2026 and long-term financial guidance

COR : 273.62 (-0.52%)
Cencora Announces Updated Fiscal Year 2026 Financial Outlook

The Board of Directors authorized a new $2.0 billion share repurchase program

COR : 273.62 (-0.52%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

NEW YORK , May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR).  Such investors are advised to contact...

COR : 273.62 (-0.52%)
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cencora, Inc. (NYSE: COR) resulting from allegations...

COR : 273.62 (-0.52%)
3 Market-Beating Stocks to Research Further

3 Market-Beating Stocks to Research Further

COR : 273.62 (-0.52%)
GILD : 127.35 (-1.40%)
MRVL : 298.29 (+13.22%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

NEW YORK , May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR).  Such investors are advised to contact...

COR : 273.62 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 283.80
2nd Resistance Point 280.89
1st Resistance Point 277.97
Last Price 273.62
1st Support Level 272.14
2nd Support Level 269.23
3rd Support Level 266.31

See More

52-Week High 377.54
Fibonacci 61.8% 326.84
Fibonacci 50% 311.18
Fibonacci 38.2% 295.52
Last Price 273.62
52-Week Low 244.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.